七月 2026
- Home
- Shilpa Medicare
七月 2026的Shilpa Medicare市场份额分析
custom peptide synthesis|shilpa avers that all business enterprises share a symbiotic relationship with society from where they draw resources for their growth. it is imperative upon enterprises to return their mite to the society and therefore there is a duty to fulfill to the communities, neighborhoods and environment in whose vicinity they operate.not only being an enterprise engaged in medicare directed towards bettering lives, shilpa wholesomely subscribes to the motto of societal obligation and is committed to materializing initiatives through practical steps also, that spell a change in the life and quality of the communities and protects the environment too.
Shilpa Medicare(包含公司地区分支机构)
查看更多网站流量和参与度信息- vbshilpa.com
Shilpa Medicare收入截至 七月 2026为 100M - 200M
Shilpa Medicare主要域名产生的收入
3 年中Shilpa Medicare主要域名的收入
Shilpa Medicare主要域名的收入
Shilpa Medicare热门域名的总访问量
了解Shilpa Medicare市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Shilpa Medicare热门域名的平均访问时长
分析Shilpa Medicare参与度指标。
过去 3 个月的平均访问时长
子公司明细
Shilpa Medicare热门域名的平均页面浏览量
了解Shilpa Medicare如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Shilpa Medicare 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Shilpa Medicare Limited had earnings of $163M on Jul 1st '26.For the financial year 2026, Shilpa Medicare Limited reported a total income of ₹1,548.71 crore.
八月 5, 2026阅读更多
新闻Shilpa Medicare Limited is developing nivolumab biosimilar for Europe on Jul 6th '26.Orion and Shilpa Medicare expand partnership to develop and supply nivolumab biosimilar for Europe.
七月 7, 2026阅读更多
查看 Shilpa Medicare 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
